Research Study

Feasibility of using the ARES Device to Measure Sleep Parameters in Men with Asymptomatic Prostate Cancer Before as well as at 6 Months after Starting Androgen Deprivation Therapy
Principal Investigator 
Larry Goldenberg

Overview

Body Locations and Systems 
Prostate Cancer
Status 
Recruiting
Study Start/End 
Jul 14, 2015 to Jun 30, 2018
Locations 
Diamond Health Care Centre
Name/Title 
Maria Spillane/Clinical Research Coordinator
Phone 
604.875.4111 Ext. 62338
Purpose of Study 

The primary purpose of our study is to examine the feasibility of using the ARESTM device to measure sleep parameters of PCa patients who are on ADT. In addition, we will also assess the feasibility of obtaining serial questionnaires from patients. In this small pilot study, we will describe subjective sleep quality, morphometric measures, urinary symptoms, hot flashes, and weight gain.

Recruitment poster

Eligibility 

Prostate cancer patients who are starting ADT and plan to be receiving treatment for at least 6 months (with or without radiation therapy).

Disclaimer 

Study Coordinators and Research Nurses cannot give medical advice over the phone. Telephone numbers and email addresses are provided for obtaining additional information on specific research studies only. If you have specific questions which require clinical expertise, please call your primary care physician.